GTABB On Other Exchanges
Symbol
Exchange
Nordic GM
London

glycorex transplantation-b (GTABB) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GLYCOREX TRANSPLANTATION-B (GTABB)
\

Related News

No related news articles were found.

glycorex transplantation-b (GTABB) Related Businessweek News

No Related Businessweek News Found

glycorex transplantation-b (GTABB) Details

Glycorex Transplantation AB (publ), a medical technology company, engages in the development, production, and sale of products for use in organ transplantation and other related disciplines. The company’s principal product is Glycosorb-ABO, which facilitates the transplantation of organs over the blood group barriers. Its product is used in the blood group-incompatible kidney, liver, heart, lungs, pancreas, and stem cells transplantation procedures. The company serves approximately 130 transplant centers in 23 countries in Europe, as well as in Australia, Canada, India, Malaysia, and Singapore. Glycorex Transplantation AB (publ) was founded in 1996 and is based in Lund, Sweden.

Founded in 1996

glycorex transplantation-b (GTABB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

glycorex transplantation-b
Glycorex Transplantation AB (publ) to Report Q1, 2019 Results on May 15, 2019

Glycorex Transplantation AB (publ) announced that they will report Q1, 2019 results on May 15, 2019

Glycorex Transplantation AB (publ), Annual General Meeting, May 22, 2019

Glycorex Transplantation AB (publ), Annual General Meeting, May 22, 2019.

Glycorex Transplantation AB (publ) to Report Fiscal Year 2018 Results on Feb 27, 2019

Glycorex Transplantation AB (publ) announced that they will report fiscal year 2018 results on Feb 27, 2019

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

GTABB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GTABB.
View Industry Companies
 

Industry Analysis

GTABB

Industry Average

Valuation GTABB Industry Range
Price/Earnings 89.7x
Price/Sales 9.0x
Price/Book 5.8x
Price/Cash Flow 55.9x
TEV/Sales 7.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GLYCOREX TRANSPLANTATION-B, please visit www.glycorex.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.